|
HS Code |
256709 |
| Product Name | Lentinan |
| Source | Shiitake mushroom (Lentinula edodes) |
| Chemical Class | Polysaccharide |
| Molecular Formula | C42H72O36 |
| Molecular Weight | 1155.01 g/mol |
| Structure Type | β-(1→3)-glucan with β-(1→6) branches |
| Appearance | White or off-white powder |
| Solubility | Water-soluble |
| Primary Use | Immunomodulator / adjunct in cancer therapy |
| Administration Route | Intravenous injection |
| Pharmacological Effect | Enhances immune system activity |
| Origin Country | Japan |
| Cas Number | 37339-90-5 |
| Stability | Stable under recommended storage conditions |
| Storage Conditions | Store in a cool, dry place away from light |
As an accredited Lentinan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Lentinan is packaged in a sealed, amber glass vial containing 50 mg of sterile, lyophilized powder, labeled with product details. |
| Shipping | Lentinan is typically shipped as a dry, stable powder at ambient temperature. It should be packed in tightly sealed containers to protect from moisture and light. For research use only, shipping complies with relevant chemical regulations. Upon receipt, store at 2-8°C for long-term preservation of quality and efficacy. |
| Storage | Lentinan should be stored in a tightly sealed container, protected from light and moisture. Keep it at -20°C in a freezer for long-term storage. Avoid repeated freeze-thaw cycles. For short-term use, it can be kept at 2–8°C. Always handle under clean, dry conditions and ensure it is kept away from strong acids and bases to maintain stability and efficacy. |
Competitive Lentinan prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Working with Lentinan goes beyond developing just another mushroom-derived beta-glucan. Our team, rooted in fermentation and purification of bioactive polysaccharides for decades, approaches every batch with the expectation that it must perform where it matters—in the research lab, in the clinic, and in finished health products. From cultivation of Lentinus edodes strains to the final QC checks, we take nothing for granted. Understanding each step lets us offer a product that reflects years spent troubleshooting, refining, and listening to those who use Lentinan daily.
We grow and extract Lentinan directly from select Lentinus edodes—shiitake mushrooms that have been monitored for bioactive content, not just yield. The harvested fruiting bodies go through a controlled hot-water extraction in stainless steel reactors, excluding solvents inconsistent with pharmaceutical standards. Our filtration systems preserve beta-1,3-glucan linkages. The end result: Lentinan as a white to off-white powder, available with certified purity levels above 95% (beta-glucan content by enzymatic hydrolysis). We monitor molecular weight, typically in the range of 500k to 800k Da, to mirror the activity published in clinical research.
Our current commercial models include food-grade and injectable-grade Lentinan. These are produced on separate lines to prevent cross-contamination. Each model has a different endotoxin threshold and is validated for its application. Our injectable model passes pyrogenicity and sterility checks required for serious parenteral applications—critically important for researchers and formulation chemists who work with human cell cultures or develop regulatory submissions.
Lentinan receives attention as an immunomodulator, specifically as a biological response modifier (BRM). It's not new in Asia—Japan’s health sector introduced it for supporting cancer therapy more than three decades ago. We entered production after noticing that multi-step extraction processes in smaller factories cut corners, often damaging the triple-helical structure that made Lentinan unique. Preserving this structure takes temperature mapping and time calibration far beyond a simple heat-and-stir approach, something our technicians perfect batch by batch.
Our experience tells us that subtitle differences—residual protein, incomplete precipitation, glycerol presence—affect both research outcomes and product stability. A powdered Lentinan that fails to dissolve evenly or forms aggregates limits dosage accuracy and storage life. We run solubility tests and size-exclusion chromatography on every lot, sending out only those batches that meet our visual and analytical standards, not just those that pass the certificate of analysis. That's what our pharmaceutical customers often look for: fewer surprises in downstream applications.
Health supplement manufacturers frequently ask us how Lentinan stands up against other beta-glucans—yeast, oat, or barley based. We remind them: Lentinan came on the scene for its backbone (β-1,3-glucan with β-1,6 branching), a configuration that seems pivotal in modulating immune system responses, as documented in hundreds of peer-reviewed studies. In our work, Lentinan's structure yields tighter activation profiles compared to the more linear glucans from oat or barley, and it shows less batch-to-batch variability than yeast-derived glucans, which can drift due to inconsistencies in fermentation substrates.
Sourcing matters, too. We've had procurement officers send us competitor samples with a wide range of functionality—some with too high protein, some with irregular molecular weight. It's not just a problem of purity or source. Lentinan, when correctly extracted, forms clear, colorless solutions with practically no odor, compared to the musty, sometimes yellowish solutions reported for certain yeast-based products. This clarity, especially in injectable models, tells formulation scientists what to expect during their own mixing and stability trials.
Pharmaceutical formulators and supplement developers value our injectable model for its tight molecular weight distribution and ultra-low endotoxin content. Their feedback led us to audit every process step, from raw mushroom inspection through multi-stage filtration. Years of collaborating with product development scientists taught us that Lentinan’s viscosity profile matters as much as its chemical identity. Poor viscosity results in unpredictable release rates in gels, injectables, or even simple drink mixes.
Our food-grade Lentinan meets strict shelf-life and sensory requirements, so supplement makers can blend it into tablets, capsules, or functional beverages. Because our finishing rooms maintain low humidity and clean air, Lentinan powder stays free-flowing until encapsulation, even after months of storage. We do not use anti-caking agents or synthetics with allergenic potential. This is not just a marketing position; it reflects our plant team's hard-earned experience watching product complaints and performance data.
Producing Lentinan at scale isn't about just cranking up extraction volume. We face real challenges with raw material variability. Not all shiitake mushrooms yield the same polysaccharide fingerprint, even with identical spawn genetics. Weather, substrate, and growth conditions continually test our quality team. We audit our growers and select only those lots meeting our in-house fingerprinting for active beta-glucan. Anything falling short gets diverted to non-Lentinan applications, never reprocessed or tolerated as a loss for the sake of filling quotas.
Protecting the triple-helical structure through extraction and precipitation takes practice. This shape is the reason Lentinan interacts predictably with immune cell receptors, and denatured structures blunt this effect. Staff at our plant know if cooling rates aren’t kept consistent or if holding temperatures wander, structural integrity breaks down—case in point, we once traced a drop in immunological activity to a malfunctioning heat exchanger. Lesson learned: redundancy and skilled supervision, not just automated sensors, keep each lot consistent.
We operate under international GMP standards, with audits from major pharmaceutical and food certification bodies. Our team invited customers in for plant tours before most trade show partnerships ever materialized, believing that seeing our extraction and QC rooms builds confidence far better than brochures or emails. Our R&D chemists work in-house, not only reviewing scientific studies but publishing our own data each year, adding to the global knowledge base.
Shipping and storage affect our results, too. Lentinan shows hygroscopic properties; once moisture content rises above 7%, it clumps or degrades. We store the powder under controlled humidity, logging batch integrity every week. We keep logistics partners on contract, not spot-market, so transit temperature excursions never put product at risk. Over the years, these choices protected us and our clients against recalls and losses due to shipping mishandling.
Researchers and pharmaceutical partners who visit our plant tell us that what sets our Lentinan apart is not just purity, but a willingness to explain every data point and outlier they request. We exchange raw HPLC files, not just interpreted graphs. On several occasions, global supplement brands shared their own analysis, confirming our declared beta-glucan values to within less than 2% deviation—a figure that beats many extract suppliers, both local and overseas.
Being the original manufacturer, we address concerns about traceability and chain of custody firsthand. End-users know which field lot contributed to each kilogram, which technician ran the pH checks, and which chromatography run captured the certificate value. In a world of relabeling and repacking, this provides reassurance that products remain consistent and up to standard, with no batch-to-batch drift unnoticed.
Countries treat Lentinan differently—classified as a prescription injectable in some markets, a traditional herbal in others, and a GRAS-listed supplement elsewhere. Our production complies with the strictest segment we serve, given that cross-contamination or residual solvents carry severe consequences in parenteral products. Over years of regulatory submissions, including filings with Asian, European, and American health authorities, we've built processes that survive audits and product recalls. This experience has shaped not only our documentation process but our day-to-day lab routines.
We recommend customers clarify the regulatory status of finished goods using Lentinan in their own jurisdictions. Our documentation package includes evidence for origin, full COA, allergen statements, and, upon request, dioxin/pesticide screenings. National regulations require evidence at lot-level, not just “meets spec” statements, so we adapt to new requests as they emerge. Familiarity with ever-changing standards protects our partners from later barriers or delays, especially for health-food launches or clinical studies.
From the factory perspective, one truth stands out: every year, downstream application standards tighten. Supplement companies adopting water-only excipient lists drive us to test and retest for trace contaminants, moving beyond minimum legal requirements. Pharmaceutical partners extend stability expectations far beyond traditional food-derived polysaccharides, asking for customized moisture-barrier packaging and even on-site release testing. We’ve responded by investing in environmental monitoring, segmented cleanroom facilities, and continuous staff training.
Our pilot laboratory, adjacent to the main production area, lets us experiment with extraction parameter tweaks and new precipitation agents. Recent work investigates lower temperature recovery protocols, keeping more native helical structure intact, and a proprietary filtration step to further reduce protein contamination below 0.5%. These advances, tested in collaboration with both external research partners and in-house analytics, may soon result in a new model tailored for monoclonal antibody co-formulations—an area we believe Lentinan can soon impact.
Lentinan’s most frequent user complaints from the past centered on clumping, microbial spoilage from open storage, and inconsistency between shipments. Years ago, we reduced clumping by switching our final drying from drum to spray processes, minimizing hot spots and uneven drying. Now, spray-dried Lentinan dissolves more quickly, crucial for both research assays and consumer beverage mixing.
Spoilage rates dropped after investments in ultra-clean packaging rooms and strict water activity control. We avoided “preservative” solutions, instead focusing on process control and clean transfer at every stage. Consistency between shipments received attention through real-time batch logging and close partnerships with our mycological suppliers. Post-harvest, each mushroom lot comes pretested for heavy metals, pesticides, and aflatoxins; shipments outside our internal limits never enter the extraction line.
Buyers today ask not only what Lentinan contains, but where it comes from and who stands behind it. As the chemicals manufacturer, we log provenance for each mushroom lot, connecting field records through extraction and purification to final QC sign-off. This provides end-users—whether supplement brand managers or clinical researchers—confidence in both quality and origin.
Practices like DNA fingerprinting of our starting Lentinus edodes strains help confirm authenticity, an important detail as industry concerns rise about adulteration and substitution. Regular audits, transparency with analytical data, and a readiness to address client queries keep us accountable in ways that generic resellers often cannot. We see this as more than compliance—it's a responsibility, reinforced by a history of long-term, repeat relationships with both small and major clients.
We believe chemical manufacturers grow by sharing applied knowledge. Our technical team participates in industry associations and scientific conferences, presenting data on Lentinan extraction, stability, and formulation compatibility. Researchers looking to compare Lentinan with other immunomodulators often consult us on protocol design, solubility management, and structural confirmation. Staying responsive informs our own production, improving process parameters based on real-world user feedback.
Through collaborative studies, we engage not just with buyers, but with academic, clinical, and regulatory partners. We’ve co-authored papers exploring Lentinan’s interaction with other biological agents and advanced analytics to detect trace contaminants. These efforts provide new learning, help set category benchmarks, and cement long-term trust in our capabilities as a genuine manufacturer—not a faceless supplier or bulk trader.
Making Lentinan that serves the industry means more than matching a spec sheet. The heart of the process lies in understanding routine plant operations, investing in skilled people, and focusing on customer outcomes. For us, this means honoring every batch as a reflection of our technical standards and personal pride. Whether supporting pharmaceutical formulation or adding strength to a nutritional smoothie, our Lentinan stands on a record of consistency, transparency, and direct experience every step of the way from spore to finished powder.